KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Short-term Investments (2017 - 2025)

Guardant Health's Short-term Investments history spans 9 years, with the latest figure at $823.4 million for Q4 2025.

  • For Q4 2025, Short-term Investments rose 161.86% year-over-year to $823.4 million; the TTM value through Dec 2025 reached $823.4 million, up 161.86%, while the annual FY2025 figure was $823.4 million, 161.86% up from the prior year.
  • Short-term Investments for Q4 2025 was $823.4 million at Guardant Health, up from $314.4 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $1.1 billion in Q1 2021 and bottomed at $35.1 million in Q4 2023.
  • The 5-year median for Short-term Investments is $697.5 million (2023), against an average of $637.5 million.
  • The largest annual shift saw Short-term Investments crashed 95.96% in 2023 before it skyrocketed 795.91% in 2024.
  • A 5-year view of Short-term Investments shows it stood at $440.5 million in 2021, then soared by 97.39% to $869.6 million in 2022, then plummeted by 95.96% to $35.1 million in 2023, then surged by 795.91% to $314.4 million in 2024, then skyrocketed by 161.86% to $823.4 million in 2025.
  • Per Business Quant, the three most recent readings for GH's Short-term Investments are $823.4 million (Q4 2025), $314.4 million (Q4 2024), and $310.7 million (Q3 2024).